Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Background: Olanzapine and quetiapine are frequently administered atypical antipsychotic medications and their effects on the corrected QT (QTc) in the critically ill population remain understudied.
Objective: The objective of this study was to compare the impact of olanzapine and quetiapine on QTc changes in critically ill patients.
Methods: This was a single-center, retrospective analysis. Adult patients admitted to the intensive care unit (ICU) from January 2023 through July 2023 were included if they received ≥2 doses of either olanzapine or quetiapine within a 48-hour period and had one QTc evaluated within 48 hours of antipsychotic initiation. The major endpoint was a composite of the incidence of QTc prolongation (defined as QTc > 500 ms or QTc > 60 ms above baseline) following antipsychotic initiation. Univariable and multivariable analyses were performed to identify risk factors for QTc prolongation.
Results: There was no statistical difference in the major composite endpoint between patients in the olanzapine and quetiapine groups (8/83 [9.6%] vs 19/129 [14.7%]; = .28). The incidence of QTc > 500 ms (7/244 [2.9%] vs 20/427 [4.7%]; = .25) and change from baseline >60 ms (5/244 [2.0%] vs 17/427 [4.0%]; = .26) were not statistically different between the olanzapine and quetiapine groups, respectively. There were no occurrences of Torsades de Pointes or extrapyramidal symptoms in either group.
Conclusion And Relevance: The results of this study suggest olanzapine and quetiapine may have similar impact on QTc prolongation in critically ill patients. These findings could contribute to safer prescribing practices in the ICU.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1177/10600280241290254 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Antipsychotic Medications for Delirium Treatment in the Pediatric Intensive Care Unit: A Systematic Review.
Paediatr Drugs
September 2025
Department of Women's and Children's Health, Pediatric Intensive Care Unit, University Hospital of Padua, Padua, Italy.
Background And Objectives: Pediatric delirium (PD) is a common but underdiagnosed condition in pediatric intensive care units (PICUs), affecting 17-66% of patients. It is associated with prolonged ventilation and hospitalization, increased healthcare costs, and mortality. While nonpharmacological approaches are considered first-line treatments, pharmacological interventions are used in refractory cases despite limited pediatric-specific evidence.
View Article and Find Full Text PDFSex-Specific Differences in Antidepressant and Antipsychotic Treatment Outcomes and Serum Levels in Children and Adolescents.
Pharmaceutics
July 2025
Department of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy, Center of Mental Health, University Hospital Wuerzburg, 97080 Wuerzburg, Germany.
Sex-specific differences in psychopharmacological treatment have gained increasing attention in adults, with studies showing that women often have higher serum concentrations of psychotropic drugs due to biological differences. However, despite recognition of these differences in adults, reference ranges for therapeutic drug monitoring (TDM) in general, but even more sex-specific therapeutic windows for psychotropic drugs, are lacking in children and adolescents, who may metabolize and respond to medications differently. The study aimed to investigate sex-specific differences in antidepressant (AD) and antipsychotic (AP) -treatment outcomes, and pharmacokinetics in childhood/adolescence.
View Article and Find Full Text PDFSexual dysfunctions related to use of antipsychotics: A protocol for a systematic review and meta-analysis.
PLoS One
August 2025
Lentis Research, Lentis Mental Health Institute, Groningen, The Netherlands.
Introduction: Sexual dysfunctions are a challenging side effect associated with antipsychotic treatment. This protocol outlines a systematic review and meta-analysis to assess the prevalence of overall sexual dysfunction, as well as the specific phases of sexual function affected by antipsychotic medications. Additionally, the analysis will explore the relationship between prolactin levels and sexual dysfunction.
View Article and Find Full Text PDFMiniature mass spectrometer-based point-of-care assay for measuring three psychiatric drugs in human plasma and whole blood.
Anal Bioanal Chem
August 2025
Department of Pharmacy, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, 330006, Nanchang, People's Republic of China.
Developing a rapid, simple method to detect psychiatric drug concentrations is essential, as it facilitates long-term monitoring of treatment efficacy and is critical for managing drug poisoning in clinical settings due to abuse or accidental overdose. Conventional laboratory-based assays used for monitoring psychiatric medications often demonstrate prolonged processing times, leading to considerable delays in adjusting treatment regimens. To address this, this study introduced a point-of-care testing (POCT) approach using a miniature mass spectrometer, which allows for rapid and precise measurement of three psychiatric drugs including carbamazepine (CBZ), quetiapine (QTP), and olanzapine (OLZ) in human plasma and whole blood.
View Article and Find Full Text PDFAntipsychotic-Related Prolactin Changes: A Systematic Review and Dose-Response Meta-analysis.
CNS Drugs
August 2025
Department of Psychiatry and Psychotherapy, School of Medicine and Health, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.
Background: Prolactin increase is a common and potentially problematic adverse event of antipsychotics. We aimed to discover the relationship between antipsychotic doses and changes in prolactin levels.
Objective: To examine the relationship between antipsychotic doses and changes in prolactin levels in adults with acutely exacerbated schizophrenia.